Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by PutinKhuylo1on Feb 26, 2016 2:27pm

136 Views

Post# 24599577

RE:RE:RE:RE:RE:RE:RE:RE:RE:if SBM gets their milestones and is expected to pop..

Last I counted, fully diluted, we'd end up with around 185,000,000 shares. Not sure where you're coming from with the "continued dilution from warrants and options" comment, but there have not been any significant issuances since the last financing. There weren't a whole lotta folks stepping up to the plate 4, 3, or 2 years ago when SBM needed major help. The guys that came forward deserve at least a little reward for taking that risk.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions